ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

AMADO MAIJUB M.D., PHD

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,633Medicare Part D Prescriptions Filled, Including Refills

Rank: 189 out of 3001

$716K Total Retail Price of All Prescriptions

Rank: 273 out of 3001

550 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 550 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 550 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

4% of this provider’s 11,206 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LEVOTHYROXINE SODIUM 597 544 1 3
METOPROLOL TARTRATE 472 366 2 8
SIMVASTATIN 429 371 3 1
OMEPRAZOLE 410 280 4 4
FUROSEMIDE 395 289 5 6
AMLODIPINE BESYLATE 358 346 6 5
POTASSIUM CHLORIDE 354 281 7 15
METFORMIN HCL 342 241 8 9
ENALAPRIL MALEATE 261 229 9 83
CITALOPRAM HBR 251 203 10 16
TRAMADOL HCL 251 153 10 17
WARFARIN SODIUM 231 223 12 12
LISINOPRIL 228 181 13 2
LOSARTAN-HYDROCHLOROTHIAZIDE 220 194 14 49
SERTRALINE HCL 215 189 15 20
HYDROCODONE-ACETAMINOPHEN 210 191 S3 16 7
ZOLPIDEM TARTRATE 196 161 17 24
HYDROCHLOROTHIAZIDE 195 172 18 10
AZITHROMYCIN 174 137 19 36
PRAVASTATIN SODIUM 166 160 20 13
GLIMEPIRIDE 165 116 21 31
PREDNISONE 164 117 22 39
LOSARTAN POTASSIUM 157 133 23 21
CLOPIDOGREL 150 130 24 28
GABAPENTIN 130 98 25 14
PANTOPRAZOLE SODIUM 130 123 25 43
RANITIDINE HCL 115 99 27 41
GLYBURIDE-METFORMIN HCL 113 113 R 28 196
MELOXICAM 112 82 29 34
ATORVASTATIN CALCIUM 111 109 30 11
ESCITALOPRAM OXALATE 102 86 31 82
ALLOPURINOL 99 88 32 35
NEXIUM 98 80 33 23
SYNTHROID 98 80 33 71
PLAVIX 97 88 35 46
GLYBURIDE 96 81 R 36 62
DILTIAZEM 24HR ER 89 88 37 131
TRAMADOL HCL-ACETAMINOPHEN 86 85 38 210
DIGOXIN 84 80 39 65
CIPROFLOXACIN HCL 84 74 39 56
ADVAIR DISKUS 84 68 39 58
LANTUS 79 49 42 47
METOPROLOL SUCCINATE 79 63 42 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 78 70 44 22
SUCRALFATE 76 61 45 164
ZETIA 75 62 46 69
TRIAMTERENE-HCTZ 75 75 46 48
MUPIROCIN 74 52 48 180
PREMARIN 72 63 R 49 214
AMITRIPTYLINE HCL 69 59 R 50 85
ISOSORBIDE MONONITRATE ER 68 68 51 45
CEPHALEXIN 67 63 52 86
TRAZODONE HCL 66 54 53 37
SULFAMETHOXAZOLE-TRIMETHOPRIM 65 42 54 77
CLONIDINE HCL 63 63 55 64
JANUVIA 61 42 56 54
ATENOLOL 61 61 56 18
CRESTOR 60 47 58 33
CARVEDILOL 58 53 59 25
CYCLOBENZAPRINE HCL 58 31 R 59 73
ALENDRONATE SODIUM 58 43 59 26
KLOR-CON M10 57 53 62 138
TAMSULOSIN HCL 55 55 63 29
CELEBREX 55 37 63 89
MECLIZINE HCL 54 53 65 153
SPIRONOLACTONE 53 44 66 75
KLOR-CON M20 52 30 67 52
LABETALOL HCL 52 52 67 189
DILTIAZEM 24HR CD 51 39 69 124
LYRICA 50 31 70 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.